Recurrent Lung Non-Small Cell Carcinoma trials recruiting in Pennsylvania

All Recurrent Lung Non-Small Cell Carcinoma trials nationally

Cities in Pennsylvania

Recruiting trials in Pennsylvania

• Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
  NCT06616584 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Beaver, Butler, Chambersburg, Cranberry Township
• Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
  NCT05642572 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Altoona, Beaver, Butler, Carlisle
• MOv19-BBz CAR T Cells in FRa+ Cancers
  NCT07116057 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Philadelphia
• Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
  NCT06031688 · Phase: Phase 2 · Ages: 18 Minutes and older · Sex: All (male and female) · Pennsylvania: Chambersburg, Danville, Dickson City, Ephrata
• Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
  NCT03191149 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Pennsylvania: Allentown, Bethlehem, Bryn Mawr, Collegeville